Equibles does not estimate personal net worth.
Get an email with a short summary when Summit Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get SMMT alertsBob Duggan is recorded as CEO at Summit Therapeutics Inc. (SMMT). Bob Duggan has spoken on 9 earnings calls across 1 company, most recently for Summit Therapeutics Inc. on July 23, 2026. Summit Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Summit Therapeutics Inc. includes Glyn Edwards (CEO), Mahkam Zanganeh (CEO, COO and Board Member), Robert Duggan (CEO and Board Member) and 7 others.
“I'm very proud of the highly focused, mission-driven, patient-first team at Summit and their growing physician support around Ivinicumab, our PD-1, VEGF, Bispecific, and LEED investigational asset.”
“Not only is David correct in saying that we have a tremendous respect for the FDA, it is probably America's most respected agency around the world for its integrity, the due diligence of its work, putting patients first, and reporting into them.”
“We want to thank you for your attendance today. I only wish you could be at ESMO. There's at least 25,000 people here. We were really honored and Akeso was honored to be the first presenter at the presidential presentation with 9,000 people packed into a very large hub program.”
“As you can imagine, I'm very proud of the ongoing accomplishments of Team Summit and the continuing positive information and enthusiasm surrounding ibanissimab, our lead medicinal investigational asset.”
“I am very pleased with recent accomplishments of Team Summit and the investigational asset. In the Q4 of last year and to date in 2025, we have reached several meaningful milestones around the development of Ivinusumab, importantly with our partners in China as well as here in the U.S. and Western markets.”
Biotechnology · Healthcare
CEO
